BMS Gets CDSCO Panel Nod to Study Deucravacitinib Dr. Divya Colin20 May 2024 6:00 PM ISTNew Delhi: The drug major BMS has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Submit preliminary analysis of primary data of subjects above 18 years in India: CDSCO Panel Tells Sanofi on Amlitelimab study Dr. Divya Colin19 May 2024 6:00 PM ISTNew Delhi: After considering the phase III clinical study protocol of the monoclonal antibody Amlitelimab in the treatment of moderate-to-severe...
Use MvPI platform for reporting any adverse events linked to medical devices: CDSCO Dr. Divya Colin18 May 2024 6:00 PM ISTNew Delhi: With an aim to enhance the procedure for identifying the risk associated with Medical Devices, through a recent notification, the Ministry...
ICMR invites EoI for joint development, commercialization of Salmonella vaccine Ruchika Sharma17 May 2024 2:59 PM ISTNew Delhi: The Indian Council of Medical Research (ICMR) has issued a renewed call for Expression of Interest (EoI) from experienced Indian...
CDSCO panel agrees with Sun Pharmaceutical's Phase IV Trial Results of Cephalexin plus Clavulanate Potassium Tablets Dr. Divya Colin16 May 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has agreed to the Phase IV...
PCI issues Guidelines for Inspections of Pharmacy Institutions for academic year 2024- 2025 Dr. Divya Colin15 May 2024 6:00 PM ISTNew Delhi: The Pharmacy Council of India (PCI) has issued comprehensive guidelines for the inspection process of pharmacy institutions for the...
CDSCO Panel opins Abbott Healthcare to Conduct Phase III CT of Clarithromycin ER Tablets 1000mg Dr. Divya Colin14 May 2024 6:00 PM ISTNew Delhi: Citing that there is no specific unmet medical need, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Alkem Laboratories Gets CDSCO Panel Nod To Manufacture Market Relugolix Tablets 120mg Dr. Divya Colin13 May 2024 6:00 PM ISTNew Delhi: Alekm Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Submit Data on Paracetamol-Tapentadol Combination: CDSCO Panel tells MSN Laboratories Dr. Divya Colin12 May 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by MSN Laboratories for the fixed-dose combination (FDC) drug Paracetamol plus Tapentadol...
Submit Source Data of Phase III CT Report: CDSCO Panel Tells Eris Lifesciences on Metoprolol Succinate plus Dapagliflozin FDC Dr. Divya Colin11 May 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial report of fixed-dose combination (FDC) drug, Metoprolol Succinate sustained released 25mg/50mg plus...
Dr. Reddy's Laboratories gets CDSCO Panel Nod for BA/BE study of Ketorolac Tromethamine Sustained Release Tablet Dr. Divya Colin10 May 2024 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO Panel grants Zydus Lifscience Proposal For Additional Indication of Trivalent Influenza vaccine in 6 months to 17 years age Dr. Divya Colin9 May 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Zydus Lifscience's...
